Should growth hormone be covered for treating short stature? Newsletter Article 11 February 2013 Pages: 2 - 2
Use GP IIb/IIIa receptor antagonists in acute coronary syndromes Carlene Todd Newsletter Article 11 February 2013 Pages: 3 - 4
Access to healthcare has limited effect on outcomes? Newsletter Article 11 February 2013 Pages: 4 - 4
Epoetin-alfa not worthwhile in chemotherapy-induced anaemia Newsletter Article 11 February 2013 Pages: 6 - 6
Preventing vertical HIV transmission in rural South Africa Newsletter Article 11 February 2013 Pages: 7 - 7
Warfarin cost effective for stroke prevention in the elderly Newsletter Article 11 February 2013 Pages: 7 - 7
Which treatment for unresectable colorectal liver metastases? Newsletter Article 11 February 2013 Pages: 8 - 8
Liposomal doxorubicin good value in Kaposi’s sarcoma Newsletter Article 11 February 2013 Pages: 8 - 8
How ‘staggering’ is the economic burden of schizophrenia? Newsletter Article 11 February 2013 Pages: 9 - 9
Chemotherapy-related fatigue has sweeping impact on well-being Newsletter Article 11 February 2013 Pages: 10 - 10
Coping strategies predict variance in QOL in cystic fibrosis Newsletter Article 11 February 2013 Pages: 10 - 10
Regulatory issues for ‘Viagra’ in European countries Newsletter Article 11 February 2013 Pages: 11 - 11
Australia’s healthcare costs higher in women than men Newsletter Article 11 February 2013 Pages: 11 - 11